Sorrell decision elicits commentary from legal experts, others


The legal community and other interested parties are parsing through the Supreme Court's recent decision in Sorrell v. IMS Health Inc., to determine what the short- and long-term ramifications are of greater First Amendment protection for marketing and expanded protection of data mining. Several unresolved questions stemming from the decision are whether the FDA's current regulation of "off-label" communication by drug companies is still valid and whether the government can continue to use privacy as a justification for marketing limits. Read more.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX